Home › Soft Tissue Sarcoma › North Carolina › Charlotte
Soft Tissue Sarcoma clinical trials in Charlotte, NC
3 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
RecruitingObservational study
- Levine Cancer Institute, Charlotte
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
RecruitingPhase 2
- Levine Cancer Institute, Charlotte
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX32 studies
- New York City, NY20 studies
- Boston, MA17 studies
- Los Angeles, CA13 studies
- St. Louis, MO12 studies
- Columbus, OH12 studies
- Washington, DC11 studies
- Memphis, TN10 studies
- Philadelphia, PA9 studies
- Aurora, CO8 studies
- Nashville, TN8 studies
- Durham, NC8 studies
Other studies in Charlotte
- Cancer (all types)29 studies
- Breast Cancer22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Acute Myeloid Leukemia18 studies
- Ovarian Cancer16 studies
- Obesity16 studies
- Colorectal Cancer15 studies
- Overweight15 studies
- Metastatic Cancer12 studies
- Heart Failure12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.